Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial

Glycolysis Metabolites and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Trial

The increased prevalence of atrial fibrillation (AF) and heart failure (HF) highlights the need to better understand the mechanisms underlying these cardiovascular diseases (CVDs). In the present study, we aimed to evaluate the association between glycolysis-related metabolites and the risk of AF an...

Full description

Bibliographic Details
Main Authors: Nerea Becerra-Tomás, Miguel Ruiz-Canela, Pablo Hernández-Alonso, Mònica Bulló, Jun Li, Marta Guasch-Ferré, Estefanía Toledo, Clary B. Clish, Ramon Estruch, Emilio Ros, Montserrat Fitó, Chih-Hao Lee, Kerry Pierce, Fernando Arós, Lluís Serra-Majem, Liming Liang, Cristina Razquin, Enrique Gómez-Gracia, Miguel A. Martínez-González, Frank B. Hu, Dolores Corella, Jordi Salas-Salvadó
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Metabolites
Subjects:
glycolysis
heart failure
atrial fibrillation
PREDIMED study
Online Access:https://www.mdpi.com/2218-1989/11/5/306

Internet

https://www.mdpi.com/2218-1989/11/5/306

Similar Items